Functional mitochondria in health and disease

Frontiers in Endocrinology

Volumn 8, Issue NOV, 2017, Pages

  Herst, Patries M ^a,b   Rowe, Matthew R ^c   Carson, Georgia M ^a,c   Berridge, Michael V ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Mito nuclear cross talk; Mitochondrial DNA; Mitochondrial DNA mutations; Mitochondrial transfer, mitochondrial stress signals; Mitochondriopathies; Mitopeptides

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; SIRTUIN 3; UNTRANSLATED RNA;

ALLERGIC AIRWAY INFLAMMATION; CELL DIFFERENTIATION; CELL FUSION; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COPY NUMBER VARIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE RESPONSE; DNA REPAIR; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; EVOLUTIONARY ADAPTATION; GENE OVEREXPRESSION; HISTONE METHYLATION; HUMAN; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENOME; MITOGENESIS; MITOPHAGY; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN AGGREGATION; PROTEIN MISFOLDING; REVIEW;

EID: 85034098667     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2017.00296     Document Type: Review

References (153)

1. Chan DC. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet (2012) 46:265-87. doi:10.1146/annurev-genet-110410-132529
2. Hoitzing H, Johnston IG, Jones NS. What is the function of mitochondrial networks? A theoretical assessment of hypotheses and proposal for future research. Bioessays (2015) 37(6):687-700. doi:10.1002/bies.201400188
3. Ahn CS, Metallo CM. Mitochondria as biosynthetic factories for cancer proliferation. Cancer Metab (2015) 3(1):1-10. doi:10.1186/s40170-015-0128-2
4. Herst P, Berridge M. Plasma membrane electron transport: a new target for cancer drug development. Curr Mol Med (2006) 6:895-904. doi:10.2174/156652406779010777
5. Gregoire M, Morais R, Quilliam MA, Gravel D. On auxotrophy for pyrimidines of respiration-deficient chick embryo cells. Eur J Biochem (1984) 142(1):49-55. doi:10.1111/j.1432-1033.1984.tb08249.x
6. King MP, Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science (1989) 246(4929):500-3. doi:10.1126/science.2814477
7. Wallace DC, Fan W, Procaccio V. Mitochondrial energetics and therapeutics. Annu Rev Pathol (2010) 5:297-348. doi:10.1146/annurev.pathol.4.110807.092314
8. Wallace DC. Mitochondrial DNA in aging and disease. Nature (2016) 535(7613):498-500. doi:10.1038/nature18902
9. Coppotelli G, Ross J. Mitochondria in ageing and diseases: the super trouper of the cell. Int J Mol Sci (2016) 17(5):E711. doi:10.3390/ijms17050711
10. Deberardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Oncology (2016) 2(5):e1600200. doi:10.1126/sciadv.1600200
11. Chen Y, Zhang H, Zhou HJ, Ji W, Min W. Mitochondrial redox signaling and tumor progression. Cancers (Basel) (2016) 8(4):1-15. doi:10.3390/cancers8040040
12. Holzerová E, Prokisch H. Mitochondria: much ado about nothing? How dangerous is reactive oxygen species production? Int J Biochem Cell Biol (2015) 63:16-20. doi:10.1016/j.biocel.2015.01.021
13. Berridge MV, Herst PM, Lawen A. Targeting mitochondrial permeability in cancer drug development. Mol Nutr Food Res (2009) 53(1):76-86. doi:10.1002/mnfr.200700493
14. Halestrap A, Richardson A. The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury. J Mol Cell Cardiol (2015) 78:129-41. doi:10.1016/j.yjmcc.2014.08.018
15. Palikaras K, Lionaki E, Tavernarakis N. Mitophagy: in sickness and in health. Mol Cell Oncol (2016) 3(1):e1056332. doi:10.1080/23723556.2015.1056332
16. Ploumi C, Daskalaki I, Tavernarakis N. Mitochondrial biogenesis and clearance: a balancing act. FEBS J (2017) 284(2):183-95. doi:10.1111/febs.13820
17. Cagin U, Enriquez JA. The complex crosstalk between mitochondria and the nucleus: what goes in between? Int J Biochem Cell Biol (2015) 63:10-5. doi:10.1016/j.biocel.2015.01.026
18. Vyas S, Zaganjor E, Haigis M. Mitochondria and cancer. Cell (2016) 166:555-66. doi:10.1016/j.cell.2016.07.002
19. Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell (2016) 61(5):667-76. doi:10.1016/j.molcel.2016.02.011
20. Tran Q, Lee H, Park J, Kim S-H, Park J. Targeting cancer metabolism-revisiting the Warburg effects. Toxicol Res (2016) 32(3):177-93. doi:10.5487/TR.2016.32.3.177
21. Margulis L. Origin of Eukaryotic Cells. New Haven, CT: Yale University Press (1970)
22. Gray MW. Mitochondrial evolution. Science (2008) 283(5407):1476-81. doi:10.1126/science.283.5407.1476
23. Sicheritz-Pontén T, Kurland CG, Andersson SGE. A phylogenetic analysis of the cytochrome b and cytochrome c oxidase I genes supports an origin of mitochondria from within the Rickettsiaceae. Biochim Biophys Acta (1998) 1365(3):545-51. doi:10.1016/S0005-2728(98)00099-1
24. Margulis L, Chapman M, Guerrero R, Hall J. The last eukaryotic common ancestor (LECA): acquisition of cytoskeletal motility from aerotolerant spirochetes in the Proterozoic Eon. Proc Natl Acad Sci U S A (2006) 103(35):13080-5. doi:10.1073/pnas.0604985103
25. Spang A, Saw JH, Jørgensen SL, Zaremba-Niedzwiedzka K, Martijn J, Lind AE, et al. Complex archaea that bridge the gap between prokaryotes and eukaryotes. Nature (2015) 521(7551):173-9. doi:10.1038/nature14447
26. Gabaldon T, Huynen MA. Reconstruction of the proto-mitochondrondial metabolism. Science (2003) 301:609. doi:10.1126/science.1085463
27. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature (1981) 290:457-65. doi:10.1038/290457a0
28. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet (1999) 23(2):147. doi:10.1038/13779
29. Taanman J-W. The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta (1999) 1410:103-23. doi:10.1016/S0005-2728(98)00161-3
30. Hensen F, Cansiz S, Gerhold JM, Spelbrink JN. To be or not to be a nucleoid protein: a comparison of mass-spectrometry based approaches in the identification of potential mtDNA-nucleoid associated proteins. Biochimie (2014) 100(1):219-26. doi:10.1016/j.biochi.2013.09.017
31. Kukat C, Larsson N. MtDNA makes a U-turn for the mitochondrial nucleoid. Trends Cell Biol (2013) 23(9):457-63. doi:10.1016/j.tcb.2013.04.009
32. Garrido N, Griparic L, Jokitalo E, Wartiovaara J, van der Bliek A, Spelbrink JN. Composition and dynamics of human mitochondrial nucleoids. Mol Biol Cell (2003) 14(4):1583-96. doi:10.1091/mbc. E02-07-0399
33. Rubio-Cosials A, Solà M. U-turn DNA bending by human mitochondrial transcription factor A. Curr Opin Struct Biol (2013) 23(1):116-24. doi:10.1016/j.sbi.2012.12.004
34. Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim Biophys Acta (2012) 1819(9-10):921-9. doi:10.1016/j.bbagrm.2012.03.002
35. Kohno K, Wang K-Y, Takahashi M, Kurita T, Yoshida Y, Hirakawa M, et al. Mitochondrial transcription factor A and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy. Int J Mol Sci (2015) 16(8):19836-50. doi:10.3390/ijms160819836
36. Lane N. Mitonuclear match: optimizing fitness and fertility over generations drives ageing within generations. Bioessays (2011) 33(11):860-9. doi:10.1002/bies.201100051
37. Hofmann JN, Hosgood HD, Liu C-S, Chow W-H, Shuch B, Cheng W-L, et al. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial. Carcinogenesis (2014) 35(5):1028-31. doi:10.1093/carcin/bgt495
38. Meierhofer D, Mayr J, Foetschl U, Berger A, Fink K, Schmeller N, et al. Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis (2004) 25(6):1005-10. doi:10.1093/carcin/bgh104
39. Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, et al. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 100(15):1104-12. doi:10.1093/jnci/djn213
40. Tuppen HAL, Blakely EL, Turnbull DM, Taylor RW. Mitochondrial DNA mutations and human disease. Biochim Biophys Acta (2010) 1797(2):113-28. doi:10.1016/j.bbabio.2009.09.005
41. van Gisbergen MW, Voets AM, Starmans MHW, de Coo IFM, Yadak R, Hoffmann RF, et al. How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res (2015) 764:16-30. doi:10.1016/j.mrrev.2015.01.001
42. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A (1997) 94(2):514-9. doi:10.1073/pnas.94.2.514
43. Guliaeva N, Kuznetsova E, Gaziev A. Proteins associated with mitochondrial DNA protect it against the action of X-rays and hydrogen peroxide. Biofizika (2006) 51(4):692-7
44. Twig G, Shirihai OS. The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal (2011) 14(10):1939-51. doi:10.1089/ars.2010.3779
45. Picard M, Wallace DC, Burelle Y. The rise of mitochondria in medicine. Mitochondrion (2016) 30:105-16. doi:10.1016/j.mito.2016.07.003
46. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell (2012) 148(6):1145-59. doi:10.1016/j.cell.2012.02.035
47. Swerdlow RH. The neurodegenerative mitochondriopathies. J Alzheimers Dis (2009) 17(4):737-51. doi:10.3233/JAD-2009-1095
48. Hroudová J, Singh N, Fišar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed Res Int (2014) 2014:175062. doi:10.1155/2014/175062
49. Finsterer J. Cognitive dysfunction in mitochondrial disorders. Acta Neurol Scand (2012) 126(1):1-11. doi:10.1111/j.1600-0404.2012.01649.x
50. Li R, Guan M-X. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol Cell Biol (2010) 30(9):2147-54. doi:10.1128/MCB.01614-09
51. Ylikallio E, Suomalainen A. Mechanisms of mitochondrial diseases. Ann Med (2012) 44(1):41-59. doi:10.3109/07853890.2011.598547
52. Finsterer J, Zarrouk-Mahjoub S. Mitochondrial vasculopathy. World J Cardiol (2016) 8(5):333-9. doi:10.4330/wjc.v8.i5.333
53. Finsterer J, Frank M. Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Therap Adv Gastroenterol (2017) 10(1):142-54. doi:10.1177/1756283X16666806
54. Feichtinger RG, Sperl W, Bauer JW, Kofler B. Mitochondrial dysfunction: a neglected component of skin diseases. Exp Dermatol (2014) 23(9):607-14. doi:10.1111/exd.12484
55. Larsson NG. Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem (2010) 79:683-706. doi:10.1146/annurev-biochem-060408-093701
56. Taylor SD, Ericson NG, Burton JN, Prolla TA, Silber JR, Shendure J, et al. Targeted enrichment and high-resolution digital profiling of mitochondrial DNA deletions in human brain. Aging Cell (2014) 13(1):29-38. doi:10.1111/acel.12146
57. Iommarini L, Kurelac I, Capristo M, Calvaruso MA, Giorgio V, Bergamini C, et al. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment. Hum Mol Genet (2014) 23(6):1453-66. doi:10.1093/hmg/ddt533
58. Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, et al. MITOMAP: a human mitochondrial genome database-2004 update. Nucleic Acids Res (2005) 33(Database Iss.):2004-6
59. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature (1990) 348:651-3. doi:10.1038/348651a0
60. Sasarman F, Antonicka H, Shoubridge EA. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet (2008) 17(23):3697-707. doi:10.1093/hmg/ddn265
61. Picard M, Zhang J, Hancock S, Derbeneva O, Golhar R, Golik P, et al. Progressive increase in mtDNA 3243A > G heteroplasmy causes abrupt transcriptional reprogramming. Proc Natl Acad Sci U S A (2014) 111(38):E4033-42. doi:10.1073/pnas.1414028111
62. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand (2007) 116(1):1-14. doi:10.1111/j.1600-0404.2007.00836.x
63. Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology (1992) 42(3):545-50. doi:10.1212/WNL.42.3.545
64. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol (1994) 9(1):4-13. doi:10.1177/088307389400900102
65. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol (1984) 16(4):481-8. doi:10.1002/ana.410160409
66. Chae JH, Hwang H, Lim BC, Cheong HI, Hwang YS, Kim KJ. Clinical features of A3243G mitochondrial tRNA mutation. Brain Dev (2004) 26(4):459-62. doi:10.1016/j.braindev.2004.01.002
67. Gopisetty G, Thangarajan R. Mammalian mitochondrial ribosomal small subunit (MRPS) genes: a putative role in human disease. Gene (2016) 589(1):27-35. doi:10.1016/j.gene.2016.05.008
68. DeBalsi KL, HoffKE, Copeland WC. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res Rev (2017) 33:89-104. doi:10.1016/j.arr.2016.04.006
69. Longley MJ, Nguyen D, Kunkel TA, Copeland WC. The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem (2001) 276(42):38555-62. doi:10.1074/jbc. M105230200
70. Ding L, Liu Y. Borrowing nuclear DNA helicases to protect mitochondrial DNA. Int J Mol Sci (2015) 16(5):10870-87. doi:10.3390/ijms160510870
71. Kazak L, Reyes A, Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol (2012) 13(11):726-726. doi:10.1038/nrm3439
72. Arnould T, Michel S, Renard P. Mitochondria retrograde signaling and the UPR mt: where are we in mammals? Int J Mol Sci (2015) 16(8):18224-51. doi:10.3390/ijms160818224
73. Quinlan CL, Perevoshchikova IV, Hey-Mogensen M, Orr AL, Brand MD. Sites of reactive oxygen species generation by mitochondria oxidizing different substrates. Redox Biol (2013) 1(1):304-12. doi:10.1016/j.redox.2013.04.005
74. Shadel GS, Horvath TL. Mitochondrial ROS signaling in organismal homeostasis. Cell (2015) 163(3):560-9. doi:10.1016/j.cell.2015.10.001
75. Jin SM, Youle RJ. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy (2013) 9(11):1750-7. doi:10.4161/auto.26122
76. Maddocks ODK, Labuschagne CF, Adams PD, Vousden KH. Serine metabolism supports the methionine cycle and DNA/RNA methylation through de novo ATP synthesis in cancer cells. Mol Cell (2016) 61(2):210-21. doi:10.1016/j.molcel.2015.12.014
77. Shyh-Chang N, Locasale J, Lyssiotis C, Zheng Y, Teo R, Ratanasirintrawoot S, et al. Influence of threonine metabolism on S-adenosyl-methionine and histone methylation. Science (2013) 339(6116):222-6. doi:10.1126/science.1226603
78. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Ab. Proc Natl Acad Sci U S A (2001) 98(11):6336-41. doi:10.1073/pnas.101133498
79. Lee C, Zeng J, Drew BG, Sallam T, Martin A, Wan J, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab (2015) 21(3):443-54. doi:10.1016/j.cmet.2015.02.009
80. Cobb LJ, Lee C, Xiao J, Yen K, Wong RG, Nakamura HK, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging (Albany NY) (2016) 8(4):1-14
81. Kim S-J, Xiao J, Wan J, Cohen P, Yen K. Mitochondrial derived peptides as novel regulators of metabolism. J Physiol (2017). doi:10.1113/JP274472
82. Hoang PT, Park P, Cobb LJ, Paharkova-Vatchkova V, Hakimi M, Cohen P, et al. The neurosurvival factor Humanin inhibits beta cell apoptosis via Stat3 activation and delays and ameliorates diabetes in NOD mice. Metabolism (2010) 59(3):343. doi:10.1016/j.metabol.2009.08.001
83. Voigt A, Jelinek HF. Humanin: a mitochondrial signaling peptide as a biomarker for impaired fasting glucose-related oxidative stress. Physiol Rep (2016) 4(9):e12796. doi:10.14814/phy2.12796
84. Long Y, Tan T, Takao I, Tang B. The biochemistry and cell biology of aging: metabolic regulation through mitochondrial signaling. Am J Physiol Endocrinol Metab (2014) 30691(6):E581-91. doi:10.1152/ajpendo.00665.2013
85. Kariya S, Hirano M, Furiya Y, Sugie K, Ueno S. Humanin detected in skeletal muscles of MELAS patients: a possible new therapeutic agent. Acta Neuropathol (2005) 109:367-72. doi:10.1007/s00401-004-0965-5
86. Kin T, Sugie K, Hirano M, Goto Y, Nishino I, Ueno S. Humanin expression in skeletal muscles of patients with chronic progressive external ophthalmoplegia. J Hum Genet (2006) 51:555-8. doi:10.1007/s10038-006-0397-2
87. Lee C, Kim KH, Cohen P. MOTS-c: a novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med (2016) 100:182-7. doi:10.1016/j.freeradbiomed.2016.05.015
88. Vendramin R, Marine J, Leucci E. Non-coding RNAs: the dark side of nuclear-mitochondrial communication. EMBO J (2017) 36(9):1123-33. doi:10.15252/embj.201695546
89. Ro S, Ma H-Y, Park C, Ortogero N, Song R, Hennig GW, et al. The mitochondrial genome encodes abundant small non-coding RNAs. Cell Res (2013) 23(6):759-74. doi:10.1038/cr.2013.37
90. Gao S, Tian X, Chang H, Sun Y, Wu Z, Cheng Z, et al. Two novel lncRNAs discovered in human mitochondrial DNA using PacBio full-length transcriptome data. Mitochondrion (2017). doi:10.1016/j.mito.2017.08.002
91. Herst PM, Tan AS, Scarlett D-JG, Berridge MV. Cell surface oxygen consumption by mitochondrial gene knockout cells. Biochim Biophys Acta (2004) 1656(2-3):79-87. doi:10.1016/j.bbabio.2004.01.008
92. Herst PM, Berridge MV. Cell surface oxygen consumption: a major contributor to cellular oxygen consumption in glycolytic cancer cell lines. Biochim Biophys Acta Bioenerg (2007) 1767(2):170-7. doi:10.1016/j.bbabio.2006.11.018
93. Scarlett DJ, Herst P, Tan A, Prata C, Berridge M. Mitochondrial gene-knockout (rho0) cells: a versatile model for exploring the secrets of trans-plasma membrane electron transport. Biofactors (2004) 20(4):199-206. doi:10.1002/biof.5520200404
94. Alvero AB, O'Malley D, Brown D, Kelly G, Garg M, Chen W, et al. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer (2006) 106(3):599-608. doi:10.1002/cncr.21633
95. Choueiri TK, Mekhail T, Hutson TE, Ganapathi R, Kelly GE, Bukowski RM. Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer. Ann Oncol (2006) 17(5):860-5. doi:10.1093/annonc/mdl010
96. de Souza PL, Liauw W, Link SM, Pirabhahar S, Kelly G, Howes LG. Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol™), a novel isoflav-3-ene, in patients with advanced cancer. Cancer Chemother Pharmacol (2006) 58(4):427-33. doi:10.1007/s00280-006-0189-6
97. Herst PM, Davis JE, Neeson P, Berridge MV, Ritchie DS. The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica (2009) 94(7):928-34. doi:10.3324/haematol.2008.003996
98. Herst PM, Petersen T, Jerram P, Baty J, Berridge MV. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Biochem Pharmacol (2007) 74(11):1587-95. doi:10.1016/j.bcp.2007.08.019
99. Berridge MV, Herst PM. Tumor cell complexity and metabolic flexibility in tumorigenesis and metastasis. In: Mazurek S, Shoshan M, editors. Tumor Cell Metabolism. Vienna: Springer (2015). p. 23-43
100. Berridge MV, Herst PM, Tan AS. Metabolic flexibility and cell hierarchy in metastatic cancer. Mitochondrion (2010) 10(6):584-8. doi:10.1016/j.mito.2010.08.002
101. Herst P, Berridge M. Cell hierarchy, metabolic flexibility and systems approaches to cancer treatment. Curr Pharm Biotechnol (2013) 14(2):1-11. doi:10.2174/1389201011314030005
102. Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep (2015) 42(4):841-51. doi:10.1007/s11033-015-3858-x
103. Warburg O. On the origin of cancer cells. Nature (1956) 123(3191):309-14
104. Lu CL, Qin L, Liu HC, Candas D, Fan M, Li JJ. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition-a Warburg-reversing effect. PLoS One (2015) 10(3):1-20
105. Fernandez-Marcos P, Auwerx J. Regulation of PGC-1a, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr (2011) 93(C):884-90. doi:10.3945/ajcn.110.001917
106. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature (2012) 481(7382):463-8. doi:10.1038/nature10777
107. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, et al. PGC-1a mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol (2014) 16(10):992-1003. doi:10.1038/ncb3039
108. Kim B, Jung JW, Jung J, Han Y, Suh DH, Kim HS, et al. PGC1a induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells. Oncotarget (2017) 8(36):60299-311. doi:10.18632/oncotarget.19140
109. Gabrielson M, Björklund MY, Carlson J, Shoshan M. Expression of mitochondrial regulators PGC1a and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinoma. PLoS One (2014) 9(9):e107109. doi:10.1371/journal.pone.0107109
110. Gumeni S, Trougakos IP. Cross talk of proteostasis and mitostasis in cellular homeodynamics, ageing, and disease. Oxid Med Cell Longev (2016) 2016:1-24. doi:10.1155/2016/4587691
111. Carelli V, Maresca A, Caporali L, Trifunov S, Zanna C, Rugolo M. Mitochondria: biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations. Int J Biochem Cell Biol (2015) 63:21-4. doi:10.1016/j.biocel.2015.01.023
112. Busch KB, Kowald A, Spelbrink JN. Quality matters: how does mitochondrial network dynamics and quality control impact on mtDNA integrity? Philos Trans R Soc Lond B Biol Sci (2014) 369(1646):20130442. doi:10.1098/rstb.2013.0442
113. Mishra P, Chan DC. Metabolic regulation of mitochondrial dynamics. J Cell Biol (2016) 212(4):379-87. doi:10.1083/jcb.201511036
114. Nuebel E, Manganas P, Tokatlidis K. Orphan proteins of unknown function in the mitochondrial intermembrane space proteome: new pathways and metabolic cross-talk. Biochim Biophys Acta (2016) 1863(11):2613-23. doi:10.1016/j.bbamcr.2016.07.004
115. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A (2006) 103(5):1283-8. doi:10.1073/pnas.0510511103
116. Caicedo A, Fritz V, Brondello J-M, Ayala M, Dennemont I, Abdellaoui N, et al. MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function. Sci Rep (2015) 5(1):9073. doi:10.1038/srep09073
117. Wang X, Gerdes H-H. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ (2015) 22(7):1181-91. doi:10.1038/cdd.2014.211
118. Cho YM, Kim JH, Kim M, Park SJ, Koh SH, Ahn HS, et al. Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. PLoS One (2012) 7(3):0-7. doi:10.1371/journal.pone.0032778
119. Lou E, Fujisawa S, Morozov A, Barlas A, Romin Y, Dogan Y, et al. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. PLoS One (2012) 7(3):1-11. doi:10.1371/journal.pone.0033093
120. Pasquier J, Guerrouahen BS, Al Thawadi H, Ghiabi P, Maleki M, Abu-Kaoud N, et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med (2013) 11(1):94. doi:10.1186/1479-5876-11-94
121. Onfelt B, Nedvetzki S, Benninger RKP, Purbhoo MA, Sowinski S, Hume AN, et al. Structurally distinct membrane nanotubes between human macrophages support long-distance vesicular traffic or surfing of bacteria. J Immunol (2006) 177(12):8476-83. doi:10.4049/jimmunol.177.12.8476
122. Gerdes HH, Carvalho RN. Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol (2008) 20(4):470-5. doi:10.1016/j.ceb.2008.03.005
123. Plotnikov EY, Khryapenkova TG, Galkina SI, Sukhikh GT, Zorov DB. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture. Exp Cell Res (2010) 316(15):2447-55. doi:10.1016/j.yexcr.2010.06.009
124. Liu K, Ji K, Guo L, Wu W, Lu H, Shan P, et al. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res (2014) 92:10-8. doi:10.1016/j.mvr.2014.01.008
125. Tan AS, Baty JW, Dong LF, Bezawork-Geleta A, Endaya B, Goodwin J, et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab (2015) 21(1):81-94. doi:10.1016/j.cmet.2014.12.003
126. Dong LF, Kovarova J, Bajzikova M, Bezawork-Geleta A, Svec D, Endaya B, et al. Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells. Elife (2017) 6:e22187. doi:10.7554/eLife.22187
127. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med (2012) 18(5):759-65. doi:10.1038/nm.2736
128. Ahmad T, Mukherjee S, Pattnaik B, Kumar M, Singh S, Rehman R, et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J (2014) 33(9):994-1010. doi:10.1002/embj.201386030
129. Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, et al. Transfer of mitochondria from astrocytes to neurons after stroke Neurons can release damaged mitochondria and transfer them to astrocytes for disposal and recycling. Nature (2016) 535(7613):551-5. doi:10.1038/nature18928
130. Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood (2016) 128:253-64. doi:10.1182/blood-2015-07-655860
131. Wang Y, Cui J, Sun X, Zhang Y. Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ (2011) 18(4):732-42. doi:10.1038/cdd.2010.147
132. Wisnovsky SP, Wilson JJ, Radford RJ, Pereira MP, Chan MR, Laposa RR, et al. Targeting mitochondrial DNA with a platinum-based anticancer agent. Chem Biol (2013) 20(11):1323-8. doi:10.1016/j.chembiol.2013.08.010
133. Phinney DG, Di Giuseppe M, Njah J, Sala E, Shiva S, St Croix CM, et al. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun (2015) 6:8472. doi:10.1038/ncomms9472
134. Davis CO, Kim K-Y, Bushong EA, Mills EA, Boassa D, Shih T, et al. Transcellular degradation of axonal mitochondria. Proc Natl Acad Sci U S A (2014) 111(26):9633-8. doi:10.1073/pnas.1404651111
135. Dieriks BV, Park TI-H, Fourie C, Faull RLM, Dragunow M, Curtis MA. α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Sci Rep (2017) 7:42984. doi:10.1038/srep42984
136. Kumar A, Kim JH, Ranjan P, Metcalfe MG, Cao W, Mishina M, et al. Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Sci Rep (2017) 7:40360. doi:10.1038/srep40360
137. Zhang Y. Tunneling-nanotube: a new way of cell-cell communication. Commun Integr Biol (2011) 4(3):324-5. doi:10.4161/cib.4.3.14855
138. Gurke S, Barroso JF, Gerdes HH. The art of cellular communication: tunneling nanotubes bridge the divide. Histochem Cell Biol (2008) 129(5):539-50. doi:10.1007/s00418-008-0412-0
139. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science (2004) 303(5660):1007-10. doi:10.1126/science.1093133
140. Berridge MV, Crasso C, Neuzil J. Mitochondrial genome transfer to tumour cells breaks the rules and establishes a new precedent in cancer biology. Mol Cell Oncol (2015) 3556:1-10
141. Guescini M, Guidolin D, Vallorani L, Casadei L, Gioacchini AM, Tibollo P, et al. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp Cell Res (2010) 316(12):1977-84. doi:10.1016/j.yexcr.2010.04.006
142. Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J Neural Transm (2010) 117(1):1-4. doi:10.1007/s00702-009-0288-8
143. Jayaprakash AD, Benson EK, Gone S, Liang R, Shim J, Lambertini L, et al. Stable heteroplasmy at the single-cell level is facilitated by intercellular exchange of mtDNA. Nucleic Acids Res (2015) 43(4):2177-87. doi:10.1093/nar/gkv052
144. Falchi AM, Sogos V, Saba F, Piras M, Congiu T, Piludu M. Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochem Cell Biol (2013) 139(2):221-31. doi:10.1007/s00418-012-1045-x
145. Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell (2016) 164(6):1226-32. doi:10.1016/j.cell.2016.01.043
146. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 425(6961):968-73. doi:10.1038/nature02069
147. Ogle BM, Cascalho M, Platt JL. Biological implications of cell fusion. Nat Rev Mol Cell Biol (2005) 6(7):567-75. doi:10.1038/nrm1678
148. Weimann JM, Johansson CB, Trejo A, Blau HM. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol (2003) 5(11):959-66. doi:10.1038/ncb1053
149. Bae J-S, Furuya S, Shinoda Y, Endo S, Schuchman EH, Hirabayashi Y, et al. Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice. Hum Gene Ther (2005) 16(8):1006-11. doi:10.1089/hum.2005.16.1006
150. Giordano-Santini R, Linton C, Hilliard MA. Cell-cell fusion in the nervous system: alternative mechanisms of development, injury, and repair. Semin Cell Dev Biol (2016) 60:146-54. doi:10.1016/j.semcdb.2016.06.019
151. Osswald M, Jung E, Sahm F, Solecki G, Venkataramani V, Blaes J, et al. Brain tumour cells interconnect to a functional and resistant network. Nature (2015) 528(7580):93-8. doi:10.1038/nature16071
152. Osswald M, Solecki G, Wick W, Winkler F. A malignant cellular network in gliomas: potential clinical implications. Neuro Oncol (2016) 18(4):479-85. doi:10.1093/neuonc/now014
153. Kemp K, Wilkins A, Scolding N. Cell fusion in the brain: two cells forward, one cell back. Acta Neuropathol (2014) 128(5):629-38. doi:10.1007/s00401-014-1303-1